Albrecht P, Henke N, Tien ML, Issberner A, Bouchachia I, Maher P, Lewerenz J, Methner A. Extracellular cyclic GMP and its derivatives GMP and guanosine protect from oxidative glutamate toxicity. Neurochemistry International 2013; 62: 610-619.

Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arina H, Parsons M, Li Y, Wang J, Hertler S, Li Q, Woodward M, Simes RJ, David SDM, Chalmers J; for the INTERACT2 Investigators [Jander S]. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine 2013; 368: 2355-2365.

Anderson CS, Heeley E, Heritier S, Arima H, Woodward M, Lindley R, [Jander S]; for the INTERACT2 Investigators. Statistical analysis plan for the second INTEnsive blood pressure reduction in acute cerebral hemorrhage trial (INTERACT2): a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in the hyperacute phase of intracerebral hemorrhage. International Journal of Stroke 2013; 8: 327-328.

Antinori A, Arendt G, Grant I, Letendre S, Munoz-Moreno JA; Mind Exchange Working Group. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clinical Infectious Diseases 2013; 56: 1004-1017.

Baas H, Hagenah J, Hahne M, Redecker C, Wojtecki L, Wüllner U. Stellenwert von L-Dopa in der Therapie der Parkinson-Krankheit -Value of Levodopa Therapy for Early and Advanced Parkinson's Disease. Aktuelle Neurologie 2013; 40: 338-342.

Bräutigam L, Johansson C, Kubsch B, McDonough MA, Bill E, Holmgren A, Berndt C. An unusual mode of iron-sulfur-cluster coordination in a teleost glutaredoxin. Biochemical and Biophysical Research Communications 2013; 436: 491-496.

Bräutigam L, Jensen LD, Poschmann G, Nyström S, Bannenberg S, Dreij K, Lepka K, Prozorovski T, Montano SJ, Aktas O, Uhlén P, Stühler K, Cao Y, Holmgren A, Berndt C. Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1. Proceedings of the National Academy of Sciences of the United States of America2013; 110: 20057-20062.

Braunger BM, Pielmeier S, Demmer C, Landstorfer V, Kawall D, Abramov N, Leibinger M, Kleiter I, Fischer D, Jägle H, Tamm ER. TGFß signalling protects retinal neurons from programmed cell death during development of the mammalian eye. Journal of Neuroscience 2013; 33: 14246-14258

Brazda N, Voss C, Estrada V, Lodin H, Weinrich N, Seide K, Müller J, Müller HW. A mechanical microconnector system for restoration of tissue continuity and long-term drug application into the injured spinal cord. Biomaterials2013; 34:10056-10064.

Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA. Intravitreal aflibercept injection in macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. American Journal of Ophthalmology 2013; 155: 429-437.

Buttmann M, Kaveri S, Hartung HP. Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders. Trends in Pharmacological Sciences 2013; 34: 445-457.

Butz M. May ES, Häussinger D, Schnitzler A. The slowed brain: cortical oscillatory activity in hepatic encephalopathy. Archives of Biochemistry and Biophysics 2013; 536: 197-203.

Carey LM, Seitz RJ, Parsons M, Levi C, Farquharson S, Tournier J-D, Palmer S, Connelly A. Beyond the lesion - neuroimaging foundations for posroke recovery. Future Neurology2013; 8: 507-524.

Cheng B, Braass H, Ganos C, Treszl A, Biermann-Ruben K, Hummel FC, Müller-Vahl K, Schnitzler A, Gerloff C, Münchau A, Thomalla G. Altered intrahemispheric structural connecitivity in Gilles de la Tourette syndrome. Neuroimage Clinical 2013; 4: 174-181.

Collongues N, Marignier R, Jacob A, Leite M, Siva A, Paul F, Zephir H, Akman-Demir G, Elsone L, Jarius S, Papeix C, Mutch K, Saip S, Wildemann B, Kitley J, Karabudak R, Aktas O, Kuscu D, Altintas A, Palace J, Confavreux C, De Seze J. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder in patients with a late onset. Multiple Sclerosis 2013; 20: 1086-1094.

Comi G, Martinelli V, Rodegher M, Moiola L, Leocani L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung HP, Hillert J, King J, Komoly S, Lubetzki C, Montalban X, Myhr KM, Preziosa P, Ravnborg M, Rieckmann P, Rocca MA, Wynn D, Young C, Filippi M. Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Multiple Sclerosis 2013; 19: 1074-1083.

Comi G, Hartung HP, Kurukulasuriya NC, Greenberg SJ, Scaramozza M. Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy 2013; 14: 123-136.

Cravens PD, Kieseier BC, Hussain R, Herndon E, Arellano B, Ben LH, Timmons BC, Castro-Rojas C, Hartung HP, Hemmer B, Weber MS, Zamvil SS, Stüve O. The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 2013; 10: 67.

Croze W, Yamaguchi KD, Knappertz V, Reder AT, Salamon H. Interferon veta-1b induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics 2013; 13: 443-451.

Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proceedings of the National Academy of Sciences of the United States of America 2013; 110: 294-299.

Derksen A, Stettner M, Stöker W, Seitz RJ. Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukemia. BMJ Case Reports 2013; eMay 20; 2013.

Diekmann H, Fischer D. Glaucoma and optic nerve repair. Cell Tissue Research 2013; 353: 327-337.

Diekmann H, Leibinger M, Fischer D. Do growth-stimulated retinal ganglion cell axons find their central targets after optic nerve injury? New insights by three-dimensional imaging of the visual pathway. Experimental Neurology 2013; 248: 254-257.

Dörr J, Krautwald S, Wildemann B, Jarius S, Ringelstein M, Duning T, Aktas O, Ringelstein EB, Paul F, Kleffner I. Characteristics of Susac syndrome: a review of all reported cases. Nature Reviews Neurology 2013; 9: 307-317.

Ebstein F, Voigt A, Lange N, Warnatsch A, Schröter F, Prozorovski T, Kuckelkorn U, Aktas O, Seifert U, Kloetzel PM, Krüger E. Immunoproteasomes are important for proteostasis in immune responses. Cell 2013; 152: 935-937.

Fazekas F, Enzinger C, Schmidt R, Dichgans M, Gaertner B, Jungehulsing GJ, Hennerici MG, Heuschmann P, Holzhausen M, Kaps M, Kessler C, Martus P, Putaala J, Ropele S, Tanislav C, Tatlisumak T, Norrving B, Rolfs A, [Hartung HP]; sifap1 Investigators. MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology 2013; 81: 1914-1921.

Finis J, Enticott PG, Pollok B, Münchau A, Schnitzler A, Fitzgerald PB. Repetitive transcranial magnetic stimulation of the supplementary motor area induces echophenomena. Cortex2013; 49: 1978-1982.

Fleming A, Diekmann H, Goldsmith P. Functional characterization of the maturation of the blood-brain barrier in larval zebrafish. PLoS One 2013; 8: e77548.

Florin E, Erasmi R, Reck C, Maarouf M, Schnitzler A, Fink GR, Timmermann L. Does increased gamma activity in patients suffering from Parkinson's disease counteract the movement inhibiting beta activity? Neuroscience 2013; 237: 42-50.

Gold R, Hartung HP. Langzeittherapie mit Fingolimod bei schubförmiger MS: Sicherheits- und Wirksamkeitsdaten einer Phase-II-Extensionsstudie nach 5 Jahren. Aktuelle Neurologie2013; 40: 79-84.

Gold R, Giovannoni S, Selmaj K, Havrdova E, Montalbán X, Radue EW, Stefoski D, Robinson R, Riester K, Rana J, Elkins J, O'Neill G, [Kieseier BC]; SELECt Study Investigators. Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet 2013; 381: 2167-2175.

Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stüve O, Wiendl H, Frohman E. Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. JAMA Neurology 2013; 70: 248-251.

Hartung HP, Steinman L, Goodin DS, Comi G, Cook S, Filippi M, O'Connor P, Jeffery DR, Kappos L, Axtell R, Knappertz V, Bogumil T, Schwenke S, Croze E, Sandbrink R, Pohl C. Interleukin 17F level and interferon beta response in patients with multiple sclerosis. JAMA Neurology 2013; 70: 1017-1021.

Hartung HP, Haas J, Meergans M, Tracik F, Ortler S. Interferon-b1b in der Multiple-Sklerose-Therapie. Nervenarzt 2013; 84: 679-704.

Haupts MR, Haug C, Seidel D, Hartung HP. Multimodale Komplexbehandlung bei fortgeschrittener Multipler Sklerose. Nervenarzt 2013; 84: 723.

Hefter H, Benecke R, Erbguth F, Jost W, Reichel G, Wissel J. An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open 2013; 3: e001853.

Heiduschka P, Reininger D, Fischer D, Müller A, Hofmeister S, Schraermeyer U. Lens injury has a protective effect on photoreceptoris in the RCS rat. ISRN Ophthalmology 2013; 2013: 814814..

Heinen A, Lehmann HC, Küry P. Negative regulators of Schwann cell differentiation - novel targets for peripheral nerve therapies? Journal of Clinical Immunology 2013; 33: 18-26.

Henke N, Albrecht P, Bouchachia I, Ryazantseva M, Knoll K, Lewerenz J, Kaznacheyeva E, Maher P, Methner A. The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death & Disease 2013; 4: e470.

Hertzenberg D, Lehmann-Horn K, Kinzel S, Husterer V, Cravens PD, Kieseier BC, Hemmer B, Brück W, Zamvil SS, Stüve O, Weber MS. Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity. European Journal of Immunology 2013; 43: 2078-2088.

Heskamp A, Leibinger M, Andreadaki A, Gobrecht P, Diekmann H, Fischer D. CXCL12/SDF-1 facilitates optic nerve regeneration. Neurobiology of Disease 2013; 55: 76-86.

Hirschmann J, Özkurt TE, Butz M, Homburger M, Elben S, Hartmann CJ, Vesper J, Wojtecki L, Schnitzler A. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease. Neuroimage 2013; 68: 203-213.

Hirschmann J, Hartmann CJ, Butz M, Hoogenbom N, Özkurt TE, Elben S, Vesper J, Wojtecki L, Schnitzler A. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson`s disease. Brain 2013; 136: 3659-3670.

Hohlfeld R, Stüve O. A bird's-eye view of T cells during natalizumab therapy. Neurology2013; 81: 1372-1373.

Holz FJ, Roider J, Ogura Y, Korobelnik JF, Simader C, Groetzbach G, Vitti R, Berliner AJ, Hiemeyer F, Beckmann K, Zeitz O, Sandbrink R. VEGF Trap-eye for macular oedema secondary to central retinal vein occlusion: 6-months results of the phase III GALILEO study. British Journal of Ophthalmology 2013; 97: 278-284.

Horn A, Scheller C, du Plessis S, Arendt G, Nolting T, Joska J, Sopper S, Maschke M, Obermann M, Husstedt IW, Hain J, Maponga T, Riederer P, Koutsilieri E; German Competence Network HIV/AUDS. Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10 repeat allele which is more frequent in HIV-infected individuals. Journal of Neural Transmission 2013; 120: 1411-1419.

Jadasz JJ, Kremer D, Göttle P, Tzekova N, Domke J, Rivera FJ, Adjaye J, Hartung HP, Aigner L, Küry P. Mesenchymal stem cell conditioning promotes rat oligodendroglial cell maturation. PlosOne 2013; 8: e71814.

Jantzen SU, Ferrea S, Wach C, Quasthoff K, Illes S, Scherfeld D, Hartung HP, Seitz RJ, Dihné M. In vitro neuronal network activity in NMDA receptor encephalitis. BMC Neuroscience 2013; 14: 17.

Jost WH, Hefter H, Stenner A, Reichel G. Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy. Journal of Neural Transmission 2013; 120: 487-496.

Kahlbrock N, Butz M, May ES, Schnitzler A. Gammaband-Oszillationen hängen mit dem Grad selektiv visueller Aufmerksamkeit zusammen. Klinische Neurophysiologie 2013; 44: 18-23.

Kamp D, Krause V, Butz M, Schnitzler A, Pollok B. Changes of cortico-muscular coherence: an early marker of healthy aging? Age 2013; 35: 49-58.

Keitel A, Wojtecki L, Hirschmann J, Hartmann CJ, Ferrea S, Südmeyer M, Schnitzler A. Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation. Behavioural Brain Research 2013; 250: 199-205.

Keitel A, Ferra S, Südmeyer M, Schnitzler A, Wojtecki L. Expectation modulates the effect of deep brain stimulation on motor and cognitive function in tremor-dominant Parkinson`s disease. PLoS One 2013; 8: e81878.

Kieseier BC, Hartung HP. Targeting two-pore domain potassium channels - a promising strategy for treating T cell mediated autoimmunity (Editorial). Experimental Neurology 2013; 247: 286-288.

Kieseier BC, Stüve O, Dehmel T, Goebels N, Leussink VI, Mausberg AK, Ringelstein T, Turowski B, Aktas O, Antoch G, Hartung HP. Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. JAMA Neurology 2013; 70: 390-393.

Klotz L, Meuth SG, Kieseier BC, Wiendl H. Alemtuzumab bei schubförmig-remittierender Multipler Sklerose: Ergebnisse von zwei randomisierten kontrollierten Phase 3-Studien. Nervenarzt 2013; 84: 984-994.

Kremer D, Schichel T, Förster M, Tzekova N, Bernard C, van der Valk P, van Horssen J, Hartung HP, Perron H, Küry P. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Annals of Neurology 2013; 74: 721-732.

Kwon BK, Soril LJ, Bacon M, Beattie MS, Blesch A, Bresnahan JC, Bunge MB, Dunlop SA, Fehlings MG, Ferguson AR, Hill CE, Karimi-Abdolrezaee S, Lu P, McDonald JW, Müller HW, Oudega M, Rosenzweig ES, Reier PJ, Silver J, Sykova E, Xu XM, Guest JD, Tetzlaff W. Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough? Experimental Neurology 2013; 248: 30-44.

Lampl C, Nagl S, Arnason B, Comi G, O'Connor P, Cook S, Jeffery D, Kappos L, Filippi M, Beckmann K, Bogumil T, Pohl C, Sandbrink R, Hartung HP. Efficacy and safety of interferon beta-1b sc in older RRMS patients - a posthoc analysis of the BEYOND study. Journal of Neurology 2013; 260: 1838-1845.

Lange J, Christian N, Schnitzler a. Audio-visual congruency alters power and coherence of oscillatory activity within and between cortical areas. Neuroimage 2013; 79: 111-120.

Lee JI, Macht S, Albrecht P, Hartung HP, Goebels N. Brachial amyotrophic dipareses associated with anti-Hu positive anterior horn cell disease and autonomic disorder. Journal of Neurology 2013; 260: 301-302.

Lehmann HC, Hughes RA, Hartung HP. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Handbook of Clinical Neurology 2013; 115: 415-427.

Leibinger M, Müller A, Gobrecht P, Diekmann H, Andreadaki A, Fischer D. Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death & Disease2013; 4: e609.

Leibinger M, Andreadaki A, Diekmann H, Fischer D. Neuronal STAT3 activation is essential for CNTF and inflammatory stimulation induced CNS axon regeneration Cell Death & Disease 2013; 4: e805.

Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxidants & Redox Signaling 2013; 18: 522-555.

Lill CM, Schjeide BM, Graetz C, Liu T, Damotte V, Akkad DA, Blaschke P, Gerdes LA, Kroner A, Luessi F, Cournu-Rebeix I, Hoffjan S, Winkelmann A, Touze E, Pico F, Corcia P, Otaegui D, Antigüedad A, Alcina A, Comabella M, Montalban X, Olascoaga J, Matesanz F, Dörner T, Li SC, Steinhagen-Thiessen E, Lindenberger U, Chan A, Rieckmann P, Hartung HP, Aktas O, Lohse P, Buttmann M, Kümpfel T, Kubisch C, Zettl UK, Epplen JT, Fontaine B, Zipp F, Vandenbreock K, Bertram L. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. Journal of Medical Genetics 2013; 50: 140-143.

Lill CM, Schjeide BM, Graetz C, Ban M, Alcina A, Ortiz MA, [Hartung HP, Aktas O]; International Multiple Sclerosis Genetics Consortium. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013; 136: 1778-1782.

Lillig CH, Berndt C. Glutaredoxins in thiol/disulfide exchange. Antioxidants & Redox Signaling 2013; 18: 1654-1665.

Lillig CH, Berndt C. Cellular functions of glutathione Preface. BBA - General Subjects 2013; 1830: 3137-3138.

Mathys C, Aissa J, Meyer zu Hörste G, Reichelt DC, Antoch G, Turowski B, Hartung HP, Sheikh KA, Lehmann HC. Peripheral neuropathy: Assessment of proximal nerve integrity by diffusion tensor imaging (DTI). Muscle & Nerve 2013; 48: 889-896.

Mausberg AK, Dorok M, Stettner M, Müller M, Hartung HP, Dehmel T, Warnke C, Meyer zu Hörste G, Kieseier BC. Recovery of the T-cell repertoire in CIDP by IV immunglobulins. Neurology 2013; 80: 296-303.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli R, Ricigliano VA, Vittori D, Fornasiero A, Buscarinu MC, [Hartung HP]; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium. A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. PlosOne 2013; 8: e63300.

Menge T, Meyer zu Hörste G. Aktuelles aus der Forschung. Aktuelle Neurologie 2013; 40: 79-84.

Müller HW. Neuroregeneration: Möglichkeiten, Chancen und Risiken der Reparatur des verletzten ZNS. In: Ebert A, Ludwig L, Ruether P (eds.). Rehabilition und Nachsorge nach Schädelhirnverletzung (Band 7) Hippocampus Verlag, Bad Honnef 2013; 82-85.

Oberwahrenbrock T, Ringelstein M, Jentschke S, Deuschle K, Klumbies K, Bellmann-Strobl J, Harmel J, Ruprecht K, Schippling S, Hartung HP, Aktas O, Brandt AU, Paul F. Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Multiple Sclerosis 2013; 19: 1887-1895.

Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Vander-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP. Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]. Multiple Sclerosis 2013; 19: 831-832.

Petri D, Pum M, Vesper J, Huston JP, Schnitzler A. GABBA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat. Behavioural Brain Research 2013; 252: 58-67.

Pfeifenbring S, Metz I, Kremer D, Küry P, Hartung HP, Brück W. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions. Glia 2013; 61: 1250-1260.

Pollok B, Kamp D, Butz M, Wojtecki L, Timmermann L, Südmeyer M, Krause V, Schnitzler A. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation? Experimental Neurology 2013; 247: 178-181.

Prochnow D, Höing B, Kleiser R, Lindenberg R, Wittsack HJ, Schäfer R, Franz M, Seitz RJ. The neural correlates of affect reading: an fMRI study on faces and gestures. Behavioural Brain Research 2013; 237: 270-277.

Prochnow D, Bermudez I, Badia S, Schmidt J, Duff A, Brunheim S, Kleiser S, Seitz RJ. Verschre PF. A functional magnetic resonance imaging study of visuomotor processing in a virtual reality-based paradigm: Rehabilitation Gaming System. European Journal of Neuroscience 2013; 37: 1441-1447.

Prochnow D, Kossack H, Brunheim S, Müller K, Wiitsack HJ, Markowitsch HJ, Seitz RJ. Processing of subliminal facial expression of emotion: a behavorial fMFR study. Society of Neurosciences 2013; 8: 448-461.

Ringelstein M, Harmel J, Distelmaier F, Ingwersen J, Menge T, Hellwig K, Kieseier B, Mayatepek E, Hartung HP, Kuempfel T, Aktas O. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Multiple Sclerosis 2013; 19: 1544-1547.

Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, [Jander S, Hartung HP]; Stroke in Young Fabry Patients (sifap) Investigators. Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke 2013; 44: 340-349.

Sartory G, Cwik J, Knuppertz H, Schürholt B, Lebens M, Seitz RJ, Schulze R. In search of the trauma memory: a meta-analysis of functional neuroimaging studies of symptom provocation in posttraumatic stress disorder (PTSD). PLoS ONE 2013; 8: e58150.

Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC. Mortality in patients with multiple sclerosis. Neurology 2013; 81: 184-192.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, [Schnitzler A, Wojtecki L]; for the EARLYSTIM-study group. Neurostimulation for Parkinson's disease with early motor complications. New England Journal of Medicine 2013; 368: 610-622.

Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfar A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H. L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients. Neurology2013; 81: 865-871.

Seide C, Voss C, Estrada V, Brazda N, Schira J, Kehl T, Antoni V, Müller HW, Müller J, Jürgens C, Faschingbauer M. Rückenmarkadaption - Bioresorbierbares Mikrosystem, Medikamentenapplikation, Stammzellen. Trauma und Berufskrankheiten 2013; 15: 179-184.

Seitz RJ, Carey LM. Neurorehabilitation after stroke. European Medical Journal Neurology2013; 1: 38-345.

Selmaj K, Li DK, Hartung HP, Hemmer B, Kappos L, Freedman MS, Stüve O, Rieckmann P, Montalban X, Ziemssen T, Auberson LZ, Pohlmann H, Mercier F, Dahlke F, Wallström E. Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study. Lancet Neurology 2013; 12: 756-767.

Shenoy AR, Dehmel T, Stettner M, Kremer D, Kieseier BC, Hartung HP, Hofstetter HH. Citalopram suppresses thymocyte cytokine production. Journal of Neuroimmunology 2013; 262: 46-52.

Singer OC, Haring HP, Trenkler J, Nolte CH, Bohner G, Reich A, Wiesmann M, Bussmeyer M, Mpotsaris A, Heumann-Haefelin T, Hoffmann C, Niederkorn K, Deutschmann H, Stoll A, Bormann A, Jander S, Turowski B, Brenck J, Schlamann MU, Petzold GC, Urbach H, Liebeskind DS, Berkefeld J. Age dependency of successful recanalization in anterior circulation strole. Cerebrovascular Disorders 2013; 36: 437-445.

Singer OC, Haring HP, Trenkler J, Nolte CH, Bohner G, Heumann-Haefelin T, Hoffmann C, Reich A, Wiesmann M, Niederkorn K, Deutschmann H, Bussmeyer M, Mpotsaris A, Stoll A, Bormann A, Petzold GC, Urbach H, Jander S, Turowski B, Schlamann M, Gröschel K, Boor S, Berkefeld J; ERNDOSTROKE Study Group. Neuroradiology 2013; 55: 1143-1151.

Stangel M, Penner IK, Kallmann BA, Lukas C, Kieseier BC, Gold M. Entwiklung eines Multifaktorenmodells zur Beurteilung des Therapie- und Krankheitsverlaufs bei schubförmig Multipler Sklerose. Aktuelle Neurologie 2013; 40: 486-493.

Steinbrink F, Evers S, Buerke B, Young P, Arendt G, Koutsilieri E, Reichelt D, Lohmann H, Husstedt IW and the German Competence Network HIV/AIDS. Cognitive im pairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. European Journal of Neurology 2013; 20: 420-428.

Stettner M, Wolffram K, Mausberg AK, Wolf C, Heikaus S, Derksen A, Dehmel T, Kieseier BC. A reliable in vitro model for studying peripheral nerve myelination in mouse. Journal of Neuroscience Methods 2013; 214: 69-79.

Stettner M, Wolffram K, Mausberg AK, Albrecht P, Derksen A, Methner A, Dehmel T, Hartung HP, Dietrich H, Kieseier BC. Correction: Promoting myelination in an in vitro mouse model of the peripheral nerve system: the effect of wine ingredients. PLOS One 2013; 8.

Treede RD, Wagner T, Kern KU, Husstedt IW, Arendt G, Birklein F, Cegla T, Freynhagen R, Gockel HH, Heskamp ML, Jager H, Joppich R, Maier C, Leffler A, Nagelein HH, Rolke R, Seddigh S, Sommer C, Stander S, Wasner G, Baron R. Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain. Current Medical Research and Oppinion 2013; 29: 527-538.

Teunissen C, Menge T, Altintas A, Alvarez-Cermeno JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Multiple Sclerosis 2013; 19: 1802-1809.

Ulrich NH, Dehmel T, Wittsack HJ, Kieseier BC, Seitz RJ. Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke. Neurological Sciences 2013; 34: 379-382.

Vanhoutte EK, Latov N, Deng C, Hanna K, Hughes R, Bril V, Dalakas MC, Donofrio P, van Doorn PA, Hartung HP, Merkies IS. Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG - the ICE study. European Journal of Neurology 2013; 20: 748-755.

Wach C, Krause V, Moliadze V, Paulus W, Schnitzler A, Pollok B. Effects of 10 Hz and 20 Hz transcranial alternating current stimulation (tACS) on motor functions and motor cortical excitability. Behavioural Brain Research 2013; 241: 1-6.

Wach C, Krause V, Moliadze V, Paulus W, Schnitzler A, Pollok B. The effect of 10 Hz transcranial alternating current stimulation (tACS) on corticomuscular coherence. Frontiers in Human Neuroscience 2013; 7: 511.

Warnke C, Pawlita M, Dehmel T, Posevitz-Fejfar A, Hartung HP, Wiendl H, Kieseier BC, Adams O. An assay to quantify species-specific anti-JC virus antibody levels in MS patients. Multiple Sclerosis 2013; 19: 1137-1144.

Warnke C, Kieseier BC, Hartung HP. Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards. Journal of Neural Transmission 2013; 120: Suppl 1: 55-60.

Warnke C, Meyer zu Hörste G, Menge T, Stüve O, Hartung HP, Wiendl H, Kieseier BC. Teriflunomid zur Behandlung der Multiplen Sklerose. Nervenarzt 2013; 84: 724-731.

Warnke C, Ramanujam R, Plavina T, Bergström T, Goelz S, Subramanyam M, Kockum I, Rahbar A, Kieseier BC, Holmen C, Olsson T, Hillert J, Fogdell-Hahn A. Changes of anti-JCV antibody levels in a Swedish national MS cohort. Journal of Neurology, Neurosurgery and Psychiatry 2013; 84: 1199-2005.

Warnke C, Mausberg AK, Stettner M, Dehmel T, Nekrich L, Meyer zu Hörste G, Hartung HP, Fogdell-Hahn A, Adams O, Kieseier BC. Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis. Neurology 2013; 81: 1400-1408.

Warnke C, Stüve O, Kieseier BC. Teriflunomide for the treatment of multiple sclerosis. Clinical Neurology & Neurosurgery 2013; 115: 90-94.

Weber A, Zimmermann C, Meyer zu Hörste G, Kieseier BC, Hartung HP, Hofstetter HH. Bacterial flagellin and diphtheria toxin co-stimulate IL-17-producing thymocytes. Cytokine2013; 64: 221-226.

Weber A, Zimmermann C, Mausberg AK, Kieseier BC, Hartung HP, Hofstetter HH. Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and GardiquimodTMInternational Immunopharmacology 2013; 17: 427-431.

Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W; EUROWILSON Consortium. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clinical Gastroenterology and Hepatology 2013; 11: 1028-1035.

Wiendl H, Kieseier BC. Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS (Editorial). Nature Reviews Neurology 2013; 9: 125-126.

Wojtecki L, Schnitzler A. Movement Disorders. In: Azari N et al. (eds.) Encyclopedia of Sciences and Religions. Thieme, New York, 2013.

Wurnig MC, Rath J, Kliner N, Höllinger J, Geissler A, Fischmeister FP, Auchhorn M, Foki T, Kronbichler M, Nickel J, Siedentopf C, Staffen W, Verius M, Golaszewski S, Koppelstätter F, Knosp E, Auff E, Felber S, Seitz RJ, Beisteiner R. Variablity of clinical functional MR imaging results: a multicentre study. Radiology 2013; 268: 521-531.

Zimmermann C, Weber A, Mausberg AK, Kieseier BC, Hartung HP, Hofstetter HH. The T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in mature and immature immune cells. Clinical and Experimental Immunology 2013; 172: 245-253.

MediathekInformation und Wissen
LageplanSo finden Sie uns